Financial Guidance and Company Overview

Halozyme's Strategic and Capital Allocation Priorities Strategic & Capital Allocation Priorities Invest to Maximize ENHANZEⓇ Revenue Growth and Durability Identify Opportunities for External Growth Potential BD Expanding Platform Technologies $ Return Capital to Shareholders Business Development Priorities Differentiated platform technologies with broad application and licensing opportunities Accretive to financial profile today with clear strategy for unlocking substantial upside Low investment requirement to execute on vision of enhancing revenue growth and durability Halozyme 4

View entire presentation